Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Selective Laser Trabeculoplasty Providing Effective Intraocular Pressure Reduction in Pigmentary Glaucoma Patients

NCT07281391 is registered in ClinicalTrials.gov with Mann Eye Institute as lead sponsor.

NCT NCT07281391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07281391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Selective Laser Trabeculoplasty Providing Effective Intraocular Pressure Reduction in Pigmentary Glaucoma Patients
Lead sponsor
Mann Eye Institute
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2026
Completion date
April 1, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pigmentary dispersion glaucoma, pigmentary dispersion syndrome